- Home
- AHG vs DNA Comparison
AHG vs DNA Comparison
Compare AHG & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- DNA
- Stock Information
- Founded
- AHG 2013
- DNA 2008
- Country
- AHG China
- DNA United States
- Employees
- AHG N/A
- DNA N/A
- Industry
- AHG Business Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AHG Consumer Discretionary
- DNA Health Care
- Exchange
- AHG Nasdaq
- DNA Nasdaq
- Market Cap
- AHG 878.7M
- DNA 895.1M
- IPO Year
- AHG N/A
- DNA N/A
- Fundamental
- Price
- AHG $1.70
- DNA $13.57
- Analyst Decision
- AHG
- DNA Strong Sell
- Analyst Count
- AHG 0
- DNA 1
- Target Price
- AHG N/A
- DNA $9.00
- AVG Volume (30 Days)
- AHG 28.5K
- DNA 1.8M
- Earning Date
- AHG 09-12-2025
- DNA 11-11-2025
- Dividend Yield
- AHG N/A
- DNA N/A
- EPS Growth
- AHG N/A
- DNA N/A
- EPS
- AHG N/A
- DNA N/A
- Revenue
- AHG $14,777,798.00
- DNA $230,815,000.00
- Revenue This Year
- AHG N/A
- DNA N/A
- Revenue Next Year
- AHG N/A
- DNA $14.41
- P/E Ratio
- AHG N/A
- DNA N/A
- Revenue Growth
- AHG 512.09
- DNA 25.21
- 52 Week Low
- AHG $0.74
- DNA $5.00
- 52 Week High
- AHG $2.35
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- AHG 51.27
- DNA 50.17
- Support Level
- AHG $1.54
- DNA $12.06
- Resistance Level
- AHG $1.70
- DNA $16.50
- Average True Range (ATR)
- AHG 0.09
- DNA 1.32
- MACD
- AHG 0.00
- DNA -0.25
- Stochastic Oscillator
- AHG 76.51
- DNA 27.72
About AHG Akso Health Group ADS
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.